PATENT CLAIM ANALYSIS

Application Number: 15935759
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210000"]

Abstract:
The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof.

Claim (Index 10):
A pharmaceutical composition comprising a therapeutically effective amount of an ACC inhibitor, a therapeutically effective amount of an FXR agonist, and a pharmaceutically acceptable carrier; wherein the ACC inhibitor is a compound of Formula (II): or a pharmaceutically acceptable salt thereof;\n and the FXR agonist is a compound of Formula (III): \n or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15508968', '15612124', '16335662', '15263033', '15753461']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685575972953255
- 35 USC 102 Novelty (BERT): 0.5232948602110816
- Combined Prediction Score: 0.7440313235869012
- Mean Citation Score: 293.449388
- Max Citation Score: 328.4005
- Similarity Product: 223.10839880967143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test